$TLS
TELOS CORP Stock $tls

$tls Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000032012124000020 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$28.50M	$29.62M
YoY Change	-13.41%	-15.91%
Cost Of Revenue	$18.79M	$18.66M
YoY Change	-8.57%	-14.18%
Gross Profit	$9.707M	$10.96M
YoY Change	-21.46%	-18.7%
Gross Profit Margin	34.06%	37.01%
Selling, General & Admin	$16.89M	$16.23M
YoY Change	-22.61%	-38.65%
% of Gross Profit	174.02%	148.06%
Research & Development	$1.459M	$3.170M
YoY Change	-44.86%	11.9%
% of Gross Profit	15.03%	28.92%
Depreciation & Amortization	$3.491M	$3.129M
YoY Change	105.84%	119.58%
% of Gross Profit	35.96%	28.55%
Operating Expenses	$18.35M	$19.40M
YoY Change	-25.01%	-33.76%
Operating Profit	-$8.644M	-$8.438M
YoY Change	-8.69%	-34.94%
Interest Expense	-$160.0K	$175.0K
YoY Change	-186.96%	-29.72%
% of Operating Profit
Other Income/Expense, Net	$1.064M	$1.252M
YoY Change	-35.48%	-49.84%
Pretax Income	-$7.740M	-$7.361M
YoY Change	-3.27%	-31.35%
Income Tax	$17.00K	$17.00K
% Of Pretax Income
Net Earnings	-$7.757M	-$7.378M
YoY Change	-3.33%	-31.34%
Net Earnings / Revenue	-27.22%	-24.91%
Basic Earnings Per Share	-$0.11	-$0.10
Diluted Earnings Per Share	-$0.11	-$0.10
COMMON SHARES
Basic Shares Outstanding	71.76M shares	70.32M shares
Diluted Shares Outstanding	72.02M shares	70.63M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$80.10M	$93.92M
YoY Change	-22.57%	-16.49%
Cash & Equivalents	$80.10M	$93.92M
Short-Term Investments
Other Short-Term Assets	$1.088M	$1.270M
YoY Change	-41.19%	21.88%
Inventory	$1.369M	$1.465M
Prepaid Expenses	$10.45M	$7.787M
Receivables	$17.18M	$18.68M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$110.2M	$123.1M
YoY Change	-25.89%	-20.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.876M	$2.907M
YoY Change	-25.14%	-34.02%
Goodwill	$17.90M	$17.90M
YoY Change	0.0%	0.0%
Intangibles	$40.72M	$40.53M
YoY Change	7.68%	19.91%
Long-Term Investments
YoY Change
Other Assets	$3.954M	$3.798M
YoY Change	273.37%	210.55%
Total Long-Term Assets	$72.20M	$72.24M
YoY Change	5.88%	10.56%
TOTAL ASSETS
Total Short-Term Assets	$110.2M	$123.1M
Total Long-Term Assets	$72.20M	$72.24M
Total Assets	$182.4M	$195.4M
YoY Change	-15.9%	-11.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.437M	$2.206M
YoY Change	-79.67%	-81.12%
Accrued Expenses	$3.356M	$6.958M
YoY Change	-25.77%	9.96%
Deferred Revenue	$5.783M	$5.993M
YoY Change	-5.78%	-16.8%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.802M	$1.766M
YoY Change	8.55%	8.68%
Total Short-Term Liabilities	$23.16M	$30.38M
YoY Change	-38.79%	-21.8%
LONG-TERM LIABILITIES
Long-Term Debt	$8.604M	$9.066M
YoY Change	-17.32%	-16.3%
Other Long-Term Liabilities	$107.0K	$106.0K
YoY Change	-64.69%	-64.78%
Total Long-Term Liabilities	$107.0K	$106.0K
YoY Change	-64.69%	-64.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.16M	$30.38M
Total Long-Term Liabilities	$107.0K	$106.0K
Total Liabilities	$33.23M	$40.96M
YoY Change	-32.63%	-19.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$290.0M	-$282.2M
YoY Change	11.88%	12.36%
Common Stock	$439.3M	$436.7M
YoY Change	2.93%	3.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$149.1M	$154.4M
YoY Change
Total Liabilities & Shareholders Equity	$182.4M	$195.4M
YoY Change	-15.9%	-11.47%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$7.757M	-$7.378M
YoY Change	-3.33%	-31.34%
Depreciation, Depletion And Amortization	$3.491M	$3.129M
YoY Change	105.84%	119.58%
Cash From Operating Activities	-$7.990M	-$350.0K
YoY Change	94.26%	250.0%
INVESTING ACTIVITIES
Capital Expenditures	$3.348M	$97.00K
YoY Change	-24.68%	-56.5%
Acquisitions
YoY Change
Other Investing Activities	-$2.150M	-$850.0K
YoY Change		50.71%
Cash From Investing Activities	-$5.498M	-$4.149M
YoY Change	41.66%	-9.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-322.0K	-$846.0K
YoY Change	-68.43%	-60.76%
NET CHANGE
Cash From Operating Activities	-7.990M	-$350.0K
Cash From Investing Activities	-5.498M	-$4.149M
Cash From Financing Activities	-322.0K	-$846.0K
Net Change In Cash	-13.81M	-$5.345M
YoY Change	53.21%	-21.89%
FREE CASH FLOW
Cash From Operating Activities	-$7.990M	-$350.0K
Capital Expenditures	$3.348M	$97.00K
Free Cash Flow	-$11.34M	-$447.0K
YoY Change	32.48%	38.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29619000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35222000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	1278000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	176000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	18658000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21740000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	10961000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	13482000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3170000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2833000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16229000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23619000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8438000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12970000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1252000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2496000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	175000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	249000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7361000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10723000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-7378000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10746000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	70628000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	68176000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70628000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	68176000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-7378000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10746000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-35000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	13000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	30000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7443000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10733000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93915000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99260000	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	18680000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	30424000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	1465000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1420000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7787000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7520000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1270000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1367000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	123117000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	139991000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2907000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3457000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6307000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6612000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	771000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	216000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	17922000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	17922000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	40530000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	39616000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3798000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	885000	usd
CY2024Q1	us-gaap	Assets Assets	195352000	usd
CY2023Q4	us-gaap	Assets Assets	208699000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9164000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	13750000	usd
CY2024Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	11233000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	14569000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5993000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6728000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1766000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1730000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	195000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	97000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2032000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2324000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	30383000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	39198000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	9066000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	9518000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	576000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	123000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	825000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	813000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	106000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	44000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	40956000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	49696000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71757998	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71757998	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70239890	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70239890	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	110000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	109000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	436616000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	433781000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-125000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-60000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-282205000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-274827000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	154396000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	159003000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	195352000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	208699000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-7378000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10746000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2984000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9499000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3129000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1425000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12000	usd
CY2024Q1	us-gaap	Accretion Expense AccretionExpense	0	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	2000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	41000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	89000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	17000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	17000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1427000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11703000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5279000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	44000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1248000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	171000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	927000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6549000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4489000	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3054000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-364000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-734000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	758000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-306000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-477000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-350000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-100000	usd
CY2024Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3202000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3800000	usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	850000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	97000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	223000	usd
CY2024Q1	tls	Payment Of Dft Holdback Amount PaymentOfDFTHoldbackAmount	0	usd
CY2023Q1	tls	Payment Of Dft Holdback Amount PaymentOfDFTHoldbackAmount	564000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4149000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4587000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	416000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	383000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	430000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1520000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	139000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	114000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-846000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2156000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5345000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6843000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99396000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119438000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94051000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	112595000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	159003000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-7378000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-35000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	30000	usd
CY2024Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-430000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1648000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1618000	usd
CY2023Q1	us-gaap	Other Restructuring Costs OtherRestructuringCosts	1300000	usd
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	-10000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	1200000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	154396000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	172354000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10746000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	13000	usd
CY2023Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1584000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7916000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1942000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	169895000	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Comparison</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior-period amounts have been reclassified to conform to the current period presentation. Starting Q3 2023, we reclassified and presented depreciation and amortization separately from the cost of sales line items. Starting Q1 2024, we reclassified sales and marketing expenses and general and administrative expenses to be presented together as selling, general and administrative expenses. The reclassifications had no net impact on gross profit, total selling, general and administrative expenses or net loss in the unaudited consolidated statements of operations.</span></div>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparing unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of revenue, expenses, assets and liabilities, and disclosure of contingent assets and liabilities. The Company regularly assesses these estimates; however, actual results could differ from those estimates. We base our estimates on historical experience, currently available information, and various other assumptions that we believe are reasonable under the circumstances.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management evaluates these estimates and assumptions on an ongoing basis, including those relating to revenue recognition on cost estimation on certain contracts, allowance for credit losses, inventory obsolescence, valuation allowance for deferred tax assets, income taxes, certain assumptions related to share-based compensation, valuation of intangible assets and goodwill, restructuring expenses accruals, and contingencies. Actual results could differ from those estimates. The impact of changes in estimates is recorded in the period in which they become known.</span></div>
CY2024Q1	us-gaap	Severance Costs1 SeveranceCosts1	-10000	usd
CY2023Q1	us-gaap	Severance Costs1 SeveranceCosts1	-100000	usd
CY2024Q1	us-gaap	Other Restructuring Costs OtherRestructuringCosts	0	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	36100000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.89
CY2023Q1	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract	0	usd
CY2024Q1	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract	0	usd
CY2023Q1	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	0	usd
CY2024Q1	tls	Bill Contracts Receivable Net Of Allowance BillContractsReceivableNetOfAllowance	8991000	usd
CY2023Q4	tls	Bill Contracts Receivable Net Of Allowance BillContractsReceivableNetOfAllowance	17818000	usd
CY2024Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	5229000	usd
CY2023Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	8022000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	4460000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	4584000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5993000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6728000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2700000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2500000	usd
CY2024Q1	us-gaap	Billed Contract Receivables BilledContractReceivables	9315000	usd
CY2023Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	18101000	usd
CY2024Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	5229000	usd
CY2023Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	8022000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	4460000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	4584000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	324000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	283000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18680000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30424000	usd
CY2024Q1	us-gaap	Inventory Gross InventoryGross	2224000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	2179000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	759000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	759000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	1465000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1420000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13385000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	39616000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19077000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16170000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2907000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19424000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15967000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3457000	usd
CY2024Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	635000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	573000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	17900000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	17900000	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	40269000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15497000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24772000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	38982000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13385000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25597000	usd
CY2024Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	56027000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15497000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	40530000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	53001000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1158000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	0	usd
CY2024Q1	tls	Intangible Assets Amortization Expense IntangibleAssetsAmortizationExpense	2112000	usd
CY2023Q1	tls	Intangible Assets Amortization Expense IntangibleAssetsAmortizationExpense	420000	usd
CY2024Q1	us-gaap	Investments Investments	3000000	usd
CY2023Q4	us-gaap	Investments Investments	0	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	136000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	136000	usd
CY2024Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	662000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	749000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3798000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	885000	usd
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	3000000	usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	900000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2206000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8307000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6958000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5443000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9164000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	13750000	usd
CY2024Q1	tls	Other Accrued Expenses Current OtherAccruedExpensesCurrent	1270000	usd
CY2023Q4	tls	Other Accrued Expenses Current OtherAccruedExpensesCurrent	1427000	usd
CY2024Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	107000	usd
CY2023Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	400000	usd
CY2024Q1	tls	Other Current Liabilities Other OtherCurrentLiabilitiesOther	655000	usd
CY2023Q4	tls	Other Current Liabilities Other OtherCurrentLiabilitiesOther	497000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2032000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2324000	usd
CY2022Q4	tls	Debt Instrument Covenant Senior Leverage Ratio Maximum DebtInstrumentCovenantSeniorLeverageRatioMaximum	3
CY2023Q2	tls	Receivables Excluded From Collateral ReceivablesExcludedFromCollateral	25000000	usd
CY2024Q1	us-gaap	Other Income OtherIncome	1400000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2984000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9499000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2176413	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.07
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	36626	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.84
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1260068	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	4.60
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	15000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.25
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	937971	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.68
CY2024Q1	tls	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding Exercisable And Vested Or Expected To Vest ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstandingExercisableAndVestedOrExpectedToVest	3900000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2100000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y8M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	400000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.80
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y4M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	740000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	400000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.80
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y1M6D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	944000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	40000.00	usd
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	38700000	usd
CY2024Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-65000	usd
CY2024Q1	tls	Incremental Common Shares Excluded From The Dilutive Effect IncrementalCommonSharesExcludedFromTheDilutiveEffect	43800	shares
CY2023Q1	tls	Incremental Common Shares Excluded From The Dilutive Effect IncrementalCommonSharesExcludedFromTheDilutiveEffect	265608	shares
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29619000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35222000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	10961000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	13482000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3170000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2833000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16229000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	23619000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8438000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12970000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1252000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2496000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	175000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	249000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7361000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10723000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-7378000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10746000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93915000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99260000	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	136000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	136000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94051000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99396000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	146000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	219000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	626000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	117000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	154000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	273000	usd
CY2024Q1	tls	Purchase Of Investment In Accounts Payable And Other Accrued Liabilities PurchaseOfInvestmentInAccountsPayableAndOtherAccruedLiabilities	2150000	usd
CY2023Q1	tls	Purchase Of Investment In Accounts Payable And Other Accrued Liabilities PurchaseOfInvestmentInAccountsPayableAndOtherAccruedLiabilities	0	usd
CY2024Q1	tls	Issuance Of Common Stock For401 K Match IssuanceOfCommonStockFor401KMatch	1618000	usd
CY2023Q1	tls	Issuance Of Common Stock For401 K Match IssuanceOfCommonStockFor401KMatch	1942000	usd
CY2024Q1	tls	Intangible Assets Transferred To Extinguish Other Financing Obligations IntangibleAssetsTransferredToExtinguishOtherFinancingObligations	0	usd
CY2023Q1	tls	Intangible Assets Transferred To Extinguish Other Financing Obligations IntangibleAssetsTransferredToExtinguishOtherFinancingObligations	7089000	usd
CY2024Q1	tls	Withholding Tax On Net Share Settlement Under Other Current Liabilities WithholdingTaxOnNetShareSettlementUnderOtherCurrentLiabilities	0	usd
CY2023Q1	tls	Withholding Tax On Net Share Settlement Under Other Current Liabilities WithholdingTaxOnNetShareSettlementUnderOtherCurrentLiabilities	65000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000320121-24-000020-index-headers.html	Edgar Link	pending
0000320121-24-000020-index.html	Edgar Link	pending
0000320121-24-000020.txt	Edgar Link	pending
0000320121-24-000020-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tls-20240331.htm	Edgar Link	pending
tls-20240331.xsd	Edgar Link	pending
tls-20240331xexhibit311q124.htm	Edgar Link	pending
tls-20240331xexhibit312q124.htm	Edgar Link	pending
tls-20240331xexhibit32q124.htm	Edgar Link	pending
tls-20240331_g1.jpg	Edgar Link	pending
tls-20240331_cal.xml	Edgar Link	unprocessable
tls-20240331_def.xml	Edgar Link	unprocessable
tls-20240331_lab.xml	Edgar Link	unprocessable
tls-20240331_pre.xml	Edgar Link	unprocessable
tls-20240331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TLS
TELOS CORP Stock $tls

2024 Q2 Form 10-Q Financial Statement

#000032012124000020 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLS TELOS CORP Stock $tls

2024 Q2 Form 10-Q Financial Statement

#000032012124000020 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLS
TELOS CORP Stock $tls